Latest Stories
3 Reasons ENS is Risky and 1 Stock to Buy Instead
EnerSys has been on fire lately. In the past six months alone, the company’s stock price has rocketed 89.8%, reaching $168.15 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Sotera Health Company (SHC): Buy, Sell, or Hold Post Q3 Earnings?
The past six months have been a windfall for Sotera Health Company’s shareholders. The company’s stock price has jumped 74.2%, hitting $19.18 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Martin Marietta Materials (MLM): Buy, Sell, or Hold Post Q3 Earnings?
Martin Marietta Materials has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6.2%. The stock now trades at $654.86, marking a 16.3% gain. This run-up might have investors contemplating their next move.
3 Reasons CZR is Risky and 1 Stock to Buy Instead
Over the last six months, Caesars Entertainment’s shares have sunk to $24.34, producing a disappointing 18.3% loss - a stark contrast to the S&P 500’s 10.1% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons PATH is Risky and 1 Stock to Buy Instead
UiPath trades at $14.32 and has moved in lockstep with the market. Its shares have returned 15% over the last six months while the S&P 500 has gained 10.1%.
3 Reasons to Sell DLB and 1 Stock to Buy Instead
Over the last six months, Dolby Laboratories’s shares have sunk to $62.48, producing a disappointing 16.8% loss - a stark contrast to the S&P 500’s 10.1% gain. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Roku (ROKU): Buy, Sell, or Hold Post Q3 Earnings?
Roku has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 13.1% to $103.69 per share while the index has gained 10.1%.
3 Reasons to Avoid IFF and 1 Stock to Buy Instead
Over the past six months, International Flavors & Fragrances’s stock price fell to $71.69. Shareholders have lost 6% of their capital, which is disappointing considering the S&P 500 has climbed by 10.1%. This may have investors wondering how to approach the situation.
FactSet (FDS): Buy, Sell, or Hold Post Q4 Earnings?
FactSet’s stock price has taken a beating over the past six months, shedding 31.8% of its value and falling to $288.60 per share. This may have investors wondering how to approach the situation.
3 Reasons to Sell DBD and 1 Stock to Buy Instead
Diebold Nixdorf has had an impressive run over the past six months as its shares have beaten the S&P 500 by 8.3%. The stock now trades at $69.92, marking a 18.4% gain. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.